Annual revenue rose from KRW 6.5 billion in 2022 to KRW 14.7 billion in 2024, an increase of 100.6% year on year, and then fell 8.6% to KRW 13.4 billion in 2025. The largest year in 2022–2025 was 2024.
Operating losses of KRW 4.59 billion in 2022 and KRW 4.23 billion in 2023 gave way to an operating profit of KRW 1.02 billion in 2024, which turned the business profitable, and rose to KRW 1.51 billion in 2025, a 47.6% increase. The operating margin improved from -70.6% in 2022 and -57.8% in 2023 to 11.2% in 2025.
Net income attributable to controlling shareholders grew from KRW 944 million in 2024 to KRW 2.05 billion in 2025, a 117.3% increase, and net income including non-controlling interests was also reported at KRW 2.05 billion for 2025.
According to press reports, the 2025 profit improvement reflected both higher EPO exports and higher CDMO revenue. Operating cash flow, however, fell from KRW 2.99 billion in 2024 to KRW 190 million in 2025.
Quarterly, Q3 2025 revenue of KRW 4.01 billion and operating profit of KRW 377 million were followed by Q4 2025 revenue of KRW 2.48 billion, a 38.3% quarter-on-quarter decline, and an operating loss of KRW 404 million, which turned the quarter loss-making.
Q1 2026 revenue of KRW 3.73 billion, up 50.6% from the prior quarter, and an operating profit of KRW 482 million restored profitability.
Q2 2026 revenue rose to KRW 3.96 billion, but an operating loss of KRW 220 million turned the quarter loss-making, and press reports attributed this to higher R&D spending and one-off equipment investment for European market entry.
Q3 2026 revenue of KRW 3.97 billion rose 0.4% from the prior quarter but fell 1.0% year on year, and an operating loss of KRW 74.81 million turned the quarter loss-making compared with a year earlier.
The company said the loss reflected a production halt caused by a raw material defect and related disposal costs, and that the issue did not stem from its own process.
Net loss attributable to controlling shareholders in Q3 2026 was KRW 370 million, and cumulative net income attributable to controlling shareholders over the latest four quarters was KRW 230 million.